Showing results (171-180 of 1,083) with videos related to
Sort By:
Pageof 109
Diabetes|March 1, 2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 23, 2013
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trialPilar Jiménez-Quevedo, Lorenzo Hernando, Joan Antoni Gómez-Hospital, et al.The American Journal of Cardiology|December 27, 2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary interventionDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.Diabetes|July 28, 2005
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatmentDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 28, 2016
Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case seriesIgnacio M Seropian, Dominick J Angiolillo, Martin M Zenni, et al.Journal of the American College of Cardiology|September 12, 2009
Pharmacogenetics in cardiovascular antithrombotic therapyFrancisco Marín, Rocío González-Conejero, Piera Capranzano, et al.Clinical Pharmacokinetics|March 17, 2023
Clinical Pharmacokinetics and Pharmacodynamics of CSL112Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, et al.Revista Espanola De Cardiologia|June 7, 2011
[Assessment of dynamic coronary plaque changes and the clinical consequences in type-II diabetic patients: a serial intracoronary ultrasound study]Pilar Jiménez-Quevedo, Nobuaki Suzuki, Cecilia Corros, et al.Pageof 109